{"mainPropery":{"diseaseId":10472,"diseaseName":"L-2-hydroxyglutaric aciduria","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10472/l-2-hydroxyglutaric-aciduria","synonyms":["L-2-hydroxyglutaric acidemia"],"synonyms-with-source":[{"name":"L-2-hydroxyglutaric acidemia"}],"identifiers":[{"identifierType":"OMIM","identifierId":"236792"},{"identifierType":"ORPHANET","identifierId":"79314"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":221,"resourceName":"Organic Acidemia Association","abbreviation":"","address1":"9040 Duluth Street","address2":"","address3":"","address4":"","address5":"","city":"Golden Valley","state":"MN","zip":"55427","country":"United States","phone":"763-559-1797","tty":"","tollFree":"","fax":"866-539-4060","email":"mkstagni@gmail.com","url":"http://www.oaanews.org/","freeText":""},{"resourceID":917,"resourceName":"American Dietetic Association","address1":"120 South Riverside Plaza, Suite 2000","address2":"","address3":"","address4":"","city":"Chicago","state":"IL","zip":"60606-6995","country":"United States","phone":"","tollFree":"800-366-1655","fax":"","email":"knowledge@eatright.org","url":"http://www.eatright.org/Public/"},{"resourceID":2219,"resourceName":"Alex The Leukodystrophy Charity","abbreviation":"Alex TLC","address1":"45 Peckham High Street","address2":"","address3":"","address4":"","address5":"","city":"London","state":"","zip":"SE15 5EB","country":"United Kingdom","phone":" 020 7701 4388","tty":"","tollFree":"","fax":"","email":"info@alextlc.org","url":"https://www.alextlc.org","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/236792' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=L-2-hydroxyglutaric%20aciduria%5Btitle%5D%20AND%20hasabstract%5Btext%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss L-2-hydroxyglutaric aciduria. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/2-hydroxyglutaric-aciduria' target='_blank'>Genetics Home Reference (GHR)</a> contains information on L-2-hydroxyglutaric aciduria. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C1855995' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79314' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:236792' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":9609,"questionText":"What is L-2-hydroxyglutaric aciduria?","answerText":"<strong>L-2-hydroxyglutaric aciduria</strong> is an inherited <a href=\"https://www.nlm.nih.gov/medlineplus/metabolicdisorders.html\" target=\"_blank\">metabolic condition</a> that is associated with progressive brain damage. Signs and symptoms of this condition typically begin during infancy or early childhood and may include developmental delay, <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/003200.htm\" target=\"_blank\">seizures</a>, speech difficulties, <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/003305.htm\" target=\"_blank\">macrocephaly</a> and abnormalities in a part of the brain called the cerebellum, which is involved in coordinating movement (i.e. balance and muscle coordination). L-2-hydroxyglutaric aciduria is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <em><a href=\"http://ghr.nlm.nih.gov/gene/L2HGDH\" target=\"_blank\">L2HGDH</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.[9883][9888] Treatment is focused on alleviating the signs and symptoms of the condition, such as medications to control seizures.[9887]","dateModified":"2015-10-28T15:44:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":10761,"relatedDiseaseName":"2-Hydroxyglutaric aciduria","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":5158,"phenoTypeName":"Encephalitis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":12177,"phenoTypeName":"Intellectual disability, progressive","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5130,"phenoTypeName":"Intellectual disability, severe","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13705,"phenoTypeName":"Abnormality of extrapyramidal motor function","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13681,"phenoTypeName":"Aplasia/Hypoplasia of the cerebellum","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6005,"phenoTypeName":"Behavioral abnormality","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9851,"phenoTypeName":"Macrocephaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10333,"phenoTypeName":"Neoplasm of the nervous system","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9378,"phenoTypeName":"Spastic tetraparesis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11433,"phenoTypeName":"Dysphasia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8521,"phenoTypeName":"Abnormal pyramidal sign","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":8731,"phenoTypeName":"Cerebellar atrophy","percentRanges":"-"},{"phenoTypeId":13693,"phenoTypeName":"Corpus callosum atrophy","percentRanges":"-"},{"phenoTypeId":5154,"phenoTypeName":"Developmental regression","percentRanges":"-"},{"phenoTypeId":13847,"phenoTypeName":"Gliosis","percentRanges":"-"},{"phenoTypeId":11234,"phenoTypeName":"Global brain atrophy","percentRanges":"-"},{"phenoTypeId":11303,"phenoTypeName":"Hearing impairment","percentRanges":"-"},{"phenoTypeId":6245,"phenoTypeName":"Infantile onset","percentRanges":"-"},{"phenoTypeId":421,"phenoTypeName":"L-2-hydroxyglutaric acidemia","percentRanges":"-"},{"phenoTypeId":418,"phenoTypeName":"L-2-hydroxyglutaric aciduria","percentRanges":"-"},{"phenoTypeId":11430,"phenoTypeName":"Leukoencephalopathy","percentRanges":"-"},{"phenoTypeId":13450,"phenoTypeName":"Morphological abnormality of the pyramidal tract","percentRanges":"-"},{"phenoTypeId":10109,"phenoTypeName":"Nystagmus","percentRanges":"-"},{"phenoTypeId":10124,"phenoTypeName":"Optic atrophy","percentRanges":"-"},{"phenoTypeId":13632,"phenoTypeName":"Severe demyelination of the white matter","percentRanges":"-"},{"phenoTypeId":10498,"phenoTypeName":"Strabismus","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"L-2-hydroxyglutaric_aciduria"}